Sai‐Hong Ignatius Ou
The University of Texas MD Anderson Cancer Center(US)Central South University(CN)University of California, Irvine(US)University of California, Irvine Medical Center(US)Sichuan Provincial Hospital of Traditional Chinese Medicine(CN)Community Cancer Center(US)Second Affiliated Hospital of Chengdu University of Traditional Chinese(CN)Chengdu University of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer(2010)4,491 cited
- → Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer(2017)2,413 cited
- → Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer(2014)1,981 cited
- → STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma(2018)1,562 cited
- → ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers(2012)1,546 cited
- → Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry(2019)1,334 cited